Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Verona Pharma Plc ADR (NASDAQ: VRNA) was $41.22 for the day, up 2.90% from the previous closing price of $40.06. In other words, the price has increased by $2.90 from its previous closing price. On the day, 0.68 million shares were traded. VRNA stock price reached its highest trading level at $41.64 during the session, while it also had its lowest trading level at $39.965.
Ratios:
Our analysis of VRNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 13.03 and its Current Ratio is at 13.03. In the meantime, Its Debt-to-Equity ratio is 1.72 whereas as Long-Term Debt/Eq ratio is at 1.71.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on October 03, 2024, initiated with a Overweight rating and assigned the stock a target price of $50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 05 ’24 when ZACCARDELLI DAVID sold 640,264 shares for $5.01 per share. The transaction valued at 3,205,226 led to the insider holds 14,367,552 shares of the business.
ZACCARDELLI DAVID sold 162,800 shares of VRNA for $815,400 on Dec 06 ’24. The President and CEO now owns 14,204,752 shares after completing the transaction at $5.01 per share. On Dec 04 ’24, another insider, ZACCARDELLI DAVID, who serves as the President and CEO of the company, sold 67,608 shares for $5.00 each. As a result, the insider received 338,162 and left with 15,007,816 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRNA now has a Market Capitalization of 3373082112 and an Enterprise Value of 26770917376. For the stock, the TTM Price-to-Sale (P/S) ratio is 593.84 while its Price-to-Book (P/B) ratio in mrq is 25.85. Its current Enterprise Value per Revenue stands at 4760.12 whereas that against EBITDA is -178.12.
Stock Price History:
Over the past 52 weeks, VRNA has reached a high of $43.73, while it has fallen to a 52-week low of $11.39. The 50-Day Moving Average of the stock is 10.33%, while the 200-Day Moving Average is calculated to be 70.50%.
Shares Statistics:
VRNA traded an average of 1.01M shares per day over the past three months and 889190 shares per day over the past ten days. A total of 81.83M shares are outstanding, with a floating share count of 68.91M. Insiders hold about 15.79% of the company’s shares, while institutions hold 67.27% stake in the company. Shares short for VRNA as of 1732838400 were 6356902 with a Short Ratio of 6.30, compared to 1730332800 on 7522563. Therefore, it implies a Short% of Shares Outstanding of 6356902 and a Short% of Float of 8.1099994.
